M13B Bioequivalence for Immediate-Release Solid Oral Dosage Forms: Additional Strengths Biowaiver: Draft Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
May 30, 2025
June 2, 2025
ac185a33-db56-4b82-aaa5-ce74c415127c
Related Documents
Q3E Guideline for Extractables and Leachables
Guidance DocumentNovember 28, 2025Center for Drug Evaluation and Research
Q1 Stability Testing of Drug Substances and Drug Products: Draft Guidance for Industry
Guidance DocumentJune 23, 2025Center for Drug Evaluation and Research
M11 Clinical Electronic Structured Harmonised Protocol
Guidance DocumentDecember 21, 2022Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.